Emerging Therapies in Oncology : From Phase I and Beyond 2017

Emerging Therapies in Oncology : From Phase I and Beyond is organized by University of Texas MD Anderson Cancer Center and will be held on Nov 03, 2017 at MD Anderson Cancer Prevention Center, Houston, Texas, United States Of America.

The target audience for this medical event is physicians, fellows, investigators, study coordinators and nurses. This CME Conference has been approved for a maximum of 6.25 AMA PRA Category 1 Credits.

Course Description:
This workshop will provide a unique opportunity for oncologists and other health professionals to hear from leading experts in medical oncology as well as clinical and translational research. This educational workshop is directed toward medical oncologists, translational researchers (MDs and PhDs), and drug developers from academia and industry interested in cancer drug development. Other health professionals interested in the treatment of cancer are also invited to attend.

Conference Objectives are :
• Incorporate the appropriate referral of patients for consideration of clinical trials into clinical practice (knowledge, competence, performance);
• Incorporate the latest data on novel therapies for common cancers into clinical practice (knowledge, competence, performance);
• Assimilate the latest emerging therapies or refer patients for consideration of clinical trials to improve patient outcomes (knowledge, competence, performance, patient outcomes);
• Practice precision medicine and incorporate appropriate tests in clinical practice (knowledge, competence, performance, patient outcomes).